Cladribine — an old newcomer for pulsed immune reconstitution in MS

@article{Wiendl2017CladribineA,
  title={Cladribine — an old newcomer for pulsed immune reconstitution in MS},
  author={Heinz Wiendl},
  journal={Nature Reviews Neurology},
  year={2017},
  volume={13},
  pages={573-574}
}
The EMA has approved cladribine tablets for the treatment of multiple sclerosis. The drug is not new, and the journey to its approval has been a long one, but the old concepts that cladribine therapy are based on provide a new option for the possibility of drug-free remission.